Clinical Trials Browser

OTHER × Prostatic Neoplasms × Epirubicin × Clear all

NCT00096304 2018-04-10

Epirubicin and Docetaxel in Treating Patients With Metastatic Prostate Cancer

Phase 1 Terminated

Prostatic Neoplasms